Category: Pharmaceutical Recognition & Awards

Lucite Vial Embedment Celebrating FDA Approval

Custom Lucite, incorporating an embedded vial of Imdelltra, celebrating the approval of the drug by the Food and Drug Administration (FDA). Developed by Amgen, Imdelltra treats small cell lung cancer, a condition that afflicts about 35,000 Americans annually. (24ALJ148)

1 Image

Custom Lucite for Phase I Drug Trial

Custom Lucite celebrating the first-in-human trial of SOR 102, a treatment for nflammatory bowel disease. The drug was developed by Utah-based Sorriso Pharmaceuticals. (23AKL435)

2 Images
Side view of Lucite commemorative celebrating the first patient dosed in the clinical trial of Sorriso's SOR 102 drug.

Custom Crystal for First-Patient-Dosed Milestone

Capsule-themed custom crystal commemoratng the first patient dosed stage in the development of ACR-2316. The cancer treatment was developed by Acrivon Therapeutics, a Watertown, Massachusetts-based biopharmaceutical company. (24AKL397)

1 Image

Ogsiveo FDA Approval Commemorative

Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)

1 Image

Pill-Themed Antitrust/Patent Verdict Tombstone

Crystal tombstone celebrating a favorable verdict in an antitrust action against Gilead Sciences. The claim had centered on an earlier patent settlement involving Gilead and Teva. (23AKL380)

2 Images
Back view of pill-shaped crystal commemorating Gilead's victory in antitrust litigration.

Lucite Award with Embedded Medical Implant

Custom Award recognizing contributions to the development of a medical implant, and embedding the actual device within Lucite. (23AZH106)

2 Images
Custom Lucite recognizing contributions to the development of an implanted medical device. The award incorporates the actual device.

First Patient Dosed Clinical Trial Commemorative

Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, theĀ  drug is intended for the treatment of obstructive sleep apnea. (23AZH173)

2 Images
Side view of Lucite commemorative recognizing a clinical study of a sleep apnea therapy.

Drug Vial Embedment Celebrating FDA Approval

Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)

1 Image